by CN Bio | Aug 5, 2020 | Press releases
Appointments include James Craven as Chief Commercial Officer and Brian Manning as US Head of Sales Cambridge, UK, 05 August 2020: CN Bio, a leading cell culture company that has developed single and multi-organ microphysiological systems (MPS) to improve the accuracy...
by CN Bio | Nov 11, 2019 | Press releases
Leading bioengineering company CN Bio has launched a fee for service program providing Human Organ-on-Chip data to scientists studying non-alcoholic steatohepatitis (NASH) therapeutics. CN Bio launched the program at the American Association for the Study of Liver...
by CN Bio | May 1, 2019 | Press releases
Organ-on-Chip specialist CN Bio has signed a distribution agreement with Sydney-based AXT Pty. Ltd., Australia’s leading supplier of high technology scientific equipment. The agreement will see AXT distribute CN Bio’s innovative bioengineering products to medical...
by CN Bio | Feb 28, 2019 | Press releases
London Organ-on-Chip specialist CN Bio today announced it has secured an exclusive license to technology from the Massachusetts Institute of Technology for Organ-on-Chip systems which connect human tissues from up to 10 organs. CN Bio participated with MIT on a...
by CN Bio | Nov 22, 2018 | Press releases
The PhysioMimix™ benchtop 3D cell culture system from CN Bio has won the Innovation Award at the UK’s largest laboratory event, held at the NEC Birmingham in November. PhysioMimix™ allows researchers to set up assays and generate results quickly. Scientists and...